Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Point of Care Diagnostics Market Forecasts Growth from $20.63B (2026) to $31.46B by 2031, Profiling QuidelOrtho, Sysmex, HemoCue, Trinity Biotech & 15 Other Key Players

globenewswire.com
ABT Abbott Laboratories is mentioned as a prominent company operating in the global point-of-care diagnostics market, which is projected for significant growth. The article does not provide specific sentiment towards Abbott itself, but its inclusion suggests it's a key player in a growing sector. AMGN Amgen is not mentioned in the article. The article discusses the point-of-care diagnostics market and lists several companies, but Amgen is not among them. BDX Becton, Dickinson and Company is listed as a prominent company operating in the global point-of-care diagnostics market, which is expected to grow significantly. The article does not offer specific sentiment towards BDX, but its inclusion indicates its relevance in this expanding market. DHR Danaher Corporation is identified as a prominent player in the global point-of-care diagnostics market, a sector projected for substantial growth. The article does not express specific sentiment for Danaher, but its mention implies its significance within this expanding industry. ISRG Intuitive Surgical is not mentioned in the article. The article focuses on the point-of-care diagnostics market and lists various companies, but Intuitive Surgical is not included. QDEL QuidelOrtho Corporation is highlighted as a key player in the point-of-care diagnostics market, which is forecasted to experience significant growth. The article does not provide specific sentiment towards QuidelOrtho, but its prominent mention suggests its importance in this expanding sector. TMO Thermo Fisher Scientific Inc. is named as a prominent company within the global point-of-care diagnostics market, which is anticipated to grow substantially. The article does not offer explicit sentiment towards Thermo Fisher, but its inclusion points to its role in this developing industry. TRIB Trinity Biotech plc is identified as a key player in the global point-of-care diagnostics market, a sector projected for significant growth. The article does not provide specific sentiment for Trinity Biotech, but its mention indicates its relevance in this expanding market. XRAY DENTSPLY SIRONA Inc. is not mentioned in the article. The article discusses the point-of-care diagnostics market and lists several companies, but DENTSPLY SIRONA is not among them. BIO Bio-Rad Laboratories, Inc. is mentioned as a prominent company in the global point-of-care diagnostics market, which is expected to grow substantially. The article does not offer specific sentiment towards Bio-Rad, but its inclusion indicates its relevance in this expanding industry.

Point of Care Diagnostics Market Forecasts Growth from $20.63B (2026) to $31.46B by 2031, Profiling QuidelOrtho, Sysmex, HemoCue, Trinity Biotech & 15 Other Key Players Dublin, Sept. 16, 2026 (GLOBE NEWSWIRE) -- "Point of Care Diagnostics Market by Product, Purchase Mode, Technology, Sample, End User - Global Forecast to 2031" has been added to ResearchAndMarkets.com's offering.

The global point-of-care diagnostics market is projected to reach USD 31.46 billion by 2031, up from USD 20.63 billion in 2026, representing a compound annual growth rate of 8.8%. Market expansion is being supported by continuous technological advances and rising demand for rapid, accurate and decentralized diagnostic testing across hospitals, clinical laboratories, emergency departments, ambulatory care facilities, physician offices, retail clinics, pharmacies and home healthcare settings.

Biochemistry technology accounts for the largest share of the point-of-care diagnostics market. Its leadership reflects widespread use in blood glucose monitoring, blood gas and electrolyte analysis, cholesterol testing and other routine diagnostic applications. Broad clinical utility, cost-effectiveness and rapid result delivery continue to make biochemistry a preferred technology for high-volume point-of-care testing.

Molecular diagnostics is expected to record the fastest growth during the forecast period. Adoption is increasing for rapid PCR-based platforms used in infectious disease detection, antimicrobial resistance testing and outbreak preparedness. Innovation across immunoassays, molecular platforms, microfluidics, multiplex testing and portable analyzers is improving diagnostic accuracy, shortening turnaround times and extending testing beyond conventional laboratories. Advances in biosensors, artificial intelligence-enabled diagnostics and smartphone-integrated testing solutions are also supporting next-generation point-of-care diagnostic adoption.

Key Market Segment Insights

North America Leads the Global Point-of-Care Diagnostics Market

North America accounts for the largest regional market share, supported by advanced healthcare infrastructure, strong reimbursement frameworks and widespread adoption of decentralized diagnostics. Hospitals, clinical laboratories, physician offices, urgent care centers, retail clinics and pharmacies across the region routinely use point-of-care diagnostics to detect and manage infectious diseases, diabetes, cardiovascular disorders and respiratory conditions.

High healthcare expenditure, favorable regulatory support and the presence of leading diagnostic manufacturers have accelerated adoption in the United States and Canada. The growing focus on early diagnosis, improved patient outcomes and lower healthcare costs through near-patient testing is expected to sustain North America's market leadership.

Competitive Landscape

Prominent companies operating in the global point-of-care diagnostics market include Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), Siemens Healthineers AG (Germany), QuidelOrtho Corporation (US), bioMerieux SA (France), Werfen S.A. (Spain), Becton, Dickinson and Company (US), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific Inc. (US), OraSure Technologies, Inc. (US), EKE Diagnostics (China), Trinity Biotech plc (Ireland), Grifols S.A. (Spain), Nova Biomedical Corporation (US), Sekisui Diagnostics, LLC (US), Trividia Health, Inc. (US), Sysmex Corporation (Japan), HemoCue AB (Sweden) and Bio-Rad Laboratories, Inc. (US), among others.

The competitive assessment examines market shares, growth plans, product portfolios, capabilities, company profiles, recent developments and strategic initiatives. It also reviews product launches, anticipated technology trends, investments and market expansion activities shaping competition worldwide.

Research Coverage

The report evaluates the point-of-care diagnostics market and estimates its size and growth potential by product, technology, sample, mode of purchase, end user and region. It provides analysis of established and emerging markets, competitive positioning, product enhancements, innovation pipelines, market diversification and investment activity.

Primary supply-side respondents represented a cross-section of companies, seniority levels and geographic markets:

Point-of-Care Diagnostics Market Dynamics

Reasons to Purchase the Report

The report provides market leaders and new entrants with revenue estimates for the overall point-of-care diagnostics market and its subsegments. Stakeholders can use the findings to evaluate market dynamics, identify growth opportunities, understand competitive pressures and develop effective go-to-market strategies. The research also supports product planning, geographic expansion, portfolio diversification and assessment of the growth strategies, offerings and capacities of major competitors.

Key Attributes:

Key Topics Covered:

Market Dynamics

Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/aaz9d7

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.